GT201700166A - Sal de tosilato - Google Patents

Sal de tosilato

Info

Publication number
GT201700166A
GT201700166A GT201700166A GT201700166A GT201700166A GT 201700166 A GT201700166 A GT 201700166A GT 201700166 A GT201700166 A GT 201700166A GT 201700166 A GT201700166 A GT 201700166A GT 201700166 A GT201700166 A GT 201700166A
Authority
GT
Guatemala
Prior art keywords
tosilate
salt
tosilate salt
tetrahydropirrolo
fluoropirimidin
Prior art date
Application number
GT201700166A
Other languages
English (en)
Inventor
David Andrew Coates
Craig Daniel Wolfangel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of GT201700166A publication Critical patent/GT201700166A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A UNA SAL DE TOSILATO DE N- [3-[(4AR, 7AS)-2-AMINO-6-(5-FLUOROPIRIMIDIN-2-IL)-4, 4A, 5, 7-TETRAHIDROPIRROLO [3,4-D] [1,3] TIAZIN-7A-IL]-4-FLUORO-FENIL]-5-METOXI-PIRAZINA-2-CARBOXAMIDA.
GT201700166A 2015-01-30 2017-07-27 Sal de tosilato GT201700166A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562109733P 2015-01-30 2015-01-30

Publications (1)

Publication Number Publication Date
GT201700166A true GT201700166A (es) 2018-11-23

Family

ID=55275232

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201700166A GT201700166A (es) 2015-01-30 2017-07-27 Sal de tosilato

Country Status (41)

Country Link
US (1) US10080758B2 (es)
EP (1) EP3250575B1 (es)
JP (2) JP6723250B2 (es)
KR (1) KR101950129B1 (es)
CN (1) CN107108657B (es)
AR (1) AR103406A1 (es)
AU (1) AU2016211827B2 (es)
BR (1) BR112017012149A2 (es)
CA (1) CA2969475C (es)
CL (1) CL2017001899A1 (es)
CO (1) CO2017007810A2 (es)
CR (1) CR20170287A (es)
CY (1) CY1122548T1 (es)
DK (1) DK3250575T3 (es)
DO (1) DOP2017000159A (es)
EA (1) EA031330B1 (es)
EC (1) ECSP17048768A (es)
ES (1) ES2768782T3 (es)
GT (1) GT201700166A (es)
HR (1) HRP20192240T1 (es)
HU (1) HUE048029T2 (es)
IL (1) IL252754A0 (es)
LT (1) LT3250575T (es)
MA (1) MA41420B1 (es)
MD (1) MD3250575T2 (es)
ME (1) ME03581B (es)
MX (1) MX2017009713A (es)
NZ (1) NZ732381A (es)
PE (1) PE20171333A1 (es)
PH (1) PH12017501356A1 (es)
PL (1) PL3250575T3 (es)
PT (1) PT3250575T (es)
RS (1) RS59730B1 (es)
SG (1) SG11201706038PA (es)
SI (1) SI3250575T1 (es)
SV (1) SV2017005478A (es)
TN (1) TN2017000332A1 (es)
TW (1) TWI574969B (es)
UA (1) UA119581C2 (es)
WO (1) WO2016122968A1 (es)
ZA (1) ZA201703937B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI574969B (zh) * 2015-01-30 2017-03-21 美國禮來大藥廠 甲苯磺酸鹽
WO2019094608A1 (en) 2017-11-08 2019-05-16 Denali Therapeutics Inc. Anti-bace1 antibodies and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT401651B (de) * 1994-06-14 1996-11-25 Biochemie Gmbh 7-(2-(2-aminothiazol-4-yl)-2-(z)- hydroximinoacetamido)-3-n,n- dimethylcarbamoyloxymethyl-3-cephem-4-
RU2451016C2 (ru) * 2007-12-07 2012-05-20 Пфайзер Инк. Тозилатная соль транс-n-изобутил-3-фтор-3-[3-фтор-4-(пирролидин-1-илметил)фенил]циклобутанкарбоксамида
KR101564634B1 (ko) * 2008-01-18 2015-10-30 에자이 알앤드디 매니지먼트 가부시키가이샤 축합 아미노디하이드로 티아진 유도체
TWI593692B (zh) 2013-03-12 2017-08-01 美國禮來大藥廠 四氫吡咯并噻嗪化合物
TWI570127B (zh) * 2014-09-15 2017-02-11 美國禮來大藥廠 結晶型N-[3-[(4aR,7aS)-2-胺基-6-(5-氟嘧啶-2-基)-4,4a,5,7-四氫吡咯并[3,4-d][1,3]噻嗪-7a-基]-4-氟-苯基]-5-甲氧基-吡嗪-2-甲醯胺、其用途及醫藥組合物
TWI574969B (zh) * 2015-01-30 2017-03-21 美國禮來大藥廠 甲苯磺酸鹽

Also Published As

Publication number Publication date
CN107108657B (zh) 2021-10-08
SV2017005478A (es) 2018-02-09
CL2017001899A1 (es) 2018-03-23
WO2016122968A1 (en) 2016-08-04
CA2969475C (en) 2019-06-18
CO2017007810A2 (es) 2017-10-20
PH12017501356A1 (en) 2017-12-11
KR20170097782A (ko) 2017-08-28
EA031330B1 (ru) 2018-12-28
EP3250575A1 (en) 2017-12-06
LT3250575T (lt) 2020-02-10
US10080758B2 (en) 2018-09-25
JP2019142902A (ja) 2019-08-29
MX2017009713A (es) 2017-11-17
MD3250575T2 (ro) 2020-03-31
PT3250575T (pt) 2020-01-16
PL3250575T3 (pl) 2020-06-01
CA2969475A1 (en) 2016-08-04
ZA201703937B (en) 2019-01-30
DK3250575T3 (da) 2020-01-20
DOP2017000159A (es) 2017-07-31
AU2016211827B2 (en) 2018-04-26
RS59730B1 (sr) 2020-02-28
UA119581C2 (uk) 2019-07-10
TN2017000332A1 (en) 2019-01-16
IL252754A0 (en) 2017-08-31
HRP20192240T1 (hr) 2020-03-06
SI3250575T1 (sl) 2019-12-31
JP6723250B2 (ja) 2020-07-15
CN107108657A (zh) 2017-08-29
ECSP17048768A (es) 2017-11-30
TWI574969B (zh) 2017-03-21
NZ732381A (en) 2018-05-25
SG11201706038PA (en) 2017-08-30
KR101950129B1 (ko) 2019-02-19
CR20170287A (es) 2017-07-20
MA41420B1 (fr) 2020-02-28
EA201791229A1 (ru) 2017-11-30
AR103406A1 (es) 2017-05-10
US20170368071A1 (en) 2017-12-28
AU2016211827A1 (en) 2017-06-22
PE20171333A1 (es) 2017-09-13
ES2768782T3 (es) 2020-06-23
CY1122548T1 (el) 2021-01-27
ME03581B (me) 2020-07-20
JP2018503666A (ja) 2018-02-08
EP3250575B1 (en) 2019-11-20
BR112017012149A2 (pt) 2018-01-02
HUE048029T2 (hu) 2020-05-28
TW201636354A (zh) 2016-10-16

Similar Documents

Publication Publication Date Title
AR101995A1 (es) COMPUESTOS ANTAGONISTAS DE INTEGRINA avb6
TR201905829T4 (tr) Buzdolabı.
EA201790407A1 (ru) Зонды для визуализации белка хантингтина
BR112016026942A2 (pt) geração de visualizações de direção curva por curva.
CR20170315A (es) Inhibridores bace 1 selectivos
EA201790400A1 (ru) Зонды для визуализации белка хантингтина
AR095097A1 (es) Compuestos de fenoxietoxi
UY4430S (es) “motocicleta”.
GT201700166A (es) Sal de tosilato
CL2017000645A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
CO2017001927A2 (es) Formas cristalinas de n-[3-[(4ar,7as)-2-amino-6-(5- fluoropirimidin-2-il)-4,4a,5,7-tetrahidropirrolo[3,4-d][1,3]tiazin-7a-il]-4-fluoro-fenil]-5-metoxi-pirazin-2-carboxamida como inhibidores de bace
DOP2017000016A (es) Nueva sal de disoproxilo de tenofovir
TH182870B (th) เกลือทอซิเลทของ n-[3-[(4ar,7as)-2-อะมิโน-6-(5-ฟลูออโรพิริมิดิน-2-อิล)-4,4a,5,7-เททระไฮโดรพิร์โรโล[3,4-d][1,3]ไธอะซิน-7a-อิล]-4-ฟลูออโร-เฟนิล]-5-เมธอกซิ-ไพแรซีน-2-คาร์บอกแซมีด
ГЕПАТИТА et al. 112∎ MATERIALS OF CONFERENCES∎
KR20160023503A (ko) 갑각류피자
UA112287U (xx) Застосування вінборону для нівелювання антипроліферативного впливу ібупрофену на шлунковий епітелій
ECSDI15050234S (es) Motocicleta
ECSDI15046482S (es) Motocicleta
TH1601000900A (th) สารประกอบซึ่งถูกแทนที่ด้วยควิโนลีนชนิดใหม่
TR201401768A2 (tr) Miyasteninin tedavisine yönelik bir kompozisyon.
UA93238U (uk) Комплексний препарат "глуцисаргін"
TH1601005811B (th) โครงสร้างส่วนประดับด้านหน้าของรถจักรยานยนต์
UA92398U (en) Biting signalizer
UA93524U (uk) 5-(феноксиметил)-4-феніл-4н-1,2,4-триазол-3-тіол, що проявляє жарознижуючу активність
RU2012143236A (ru) Рукав-голинище